Financials

News Ideas Discussions Technicals Forecast Seasonals

ACRV fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Acrivon Therapeutics, Inc.

Total assets of ACRV for Q2 24 is 230.59 M USD, 91.32% more than the previous Q1 24. And total liabilities increased by 15.83% in Q2 24 to 14.53 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—